Is Roivant Sciences Ltd. (ROIV) a Buy, Sell, or Hold?
NASDAQ : ROIV
Roivant Sciences Ltd. — Analyst Ratings
$33.32 USD
-$0.59 (-1.74%)
- Volume
- 5.93M
- Average Volume
- 5.81M
- Market Capitalization
- $24.07B
- P/E Ratio
- -74.04
- Dividend Yield
- 0.00%
- Price Target
- $38.00
- Year High
- $37.00
- Year Low
- $10.90
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $18.37
Analyst Consensus Summary
Consensus Rating
Sell
15 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-12.3%
vs Current Price
Price Target
$38.00
Average TargetPrice Target Range
Lowest Target
$30.00
11.1% UPSIDE
Average Target
$38.00
Median Estimate
Highest Target
$42.00
-20.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 15
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 14 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Guggenheim | Yastin Suneja | $36 | $29.96 | 2026-05-26 06:46 AM | 20.2% |
| Leerink Partners | David Risinger | $42 | $32.41 | 2026-05-21 06:20 AM | 29.6% |
| H.C. Wainwright | Douglas Tsao | $34 | $28.8147 | 2026-03-04 06:41 AM | 18.0% |
| Leerink Partners | David Risinger | $32 | $22.095 | 2025-12-15 06:19 AM | 44.8% |